Bloomberg School Researchers Support First Blood Center to Receive Full FDA Approval to Provide Convalescent Plasma for Patients Who Are Immunocompromised
Arturo Casadevall, MD, PhD, and David Sullivan, MD, recommend exploring using convalescent plasma at scale in public health preparedness planning for future disease outbreaks and pandemics.
Department of Molecular Microbiology and Immunology
